Ad
related to: abbvie bispecific antibody panel
Search results
Results from the WOW.Com Content Network
Epcoritamab, sold under the brand name Epkinly, is a monoclonal antibody anticancer medication used for the treatment of diffuse large B-cell lymphoma. [4] [7] Epcoritamab is a bispecific CD20-directed CD3 T-cell engager. [4] [7] Epcoritamab was co-developed by AbbVie and Genmab. [8]
A bispecific monoclonal antibody (BsMAb, BsAb) is an artificial protein that can simultaneously bind to two different types of antigen or two different epitopes on the same antigen. [1] Naturally occurring antibodies typically only target one antigen. BsAbs can be manufactured in several structural formats.
Bi-specific T-cell engager (BiTE) is a class of artificial bispecific monoclonal antibodies that are investigated for use as anti-cancer drugs. They direct a host's immune system, more specifically the T cells ' cytotoxic activity, against cancer cells.
sdAb: single-domain antibody; BsAb: bispecific monoclonal antibody: 3funct: trifunctional antibody; BiTE: bi-specific T-cell engager; This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Zenocutuzumab, sold under the brand name Bizengri, is a humanized monoclonal antibody used for the treatment of non-small cell lung cancer or pancreatic cancer. [1] It is a low-fucose humanized full-length immunoglobulin G1 bispecific HER2- and HER3-directed antibody.
Lawmakers on the Senate Intelligence Committee peppered director of national intelligence nominee Tulsi Gabbard with questions about her controversial rhetoric on Russian aggression, Syria’s use ...
Along scFv and Fab fragments, diabodies or bispecific recombinant antibodies are the third major format. [5] Bispecific antibodies combine two different antigen binding specificities within one molecule. [10] The bispecific antibodies are used to crosslink the target molecules with two different cells and mediate direct cytotoxicity. [13] [14]
Ad
related to: abbvie bispecific antibody panel